Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinhai Medical TechnologyHKSE:02225 -6.22%61 Quick Ratio is 1.75 as of Dec. 2025, which is 23% below its 10-year median of 2.26. GuruFocus rates HKSE:02225 with a GF Score™ of 61/100 and a GF Value™ of HK$1.41 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 550 Conglomerates companies, Jinhai Medical Technology ranks better than 69.82% on this metric.
Jinhai Medical Technology (HKSE:02225) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Jinhai Medical Technology Quick Ratio Related Terms
Jinhai Medical Technology Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02225 vs RHI, KFY, TNET: Quick Ratio Comparison
For the Conglomerates subindustry, Jinhai Medical Technology's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinhai Medical Technology Quick Ratio vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Jinhai Medical Technology's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Jinhai Medical Technology's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Jinhai Medical Technology's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinhai Medical Technology (HKSE:02225) has a Quick Ratio of 1.75 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Jinhai Medical Technology and its competitors. This is 23% below median its historical median of 2.26. Over the past decade, Jinhai Medical Technology's Quick Ratio has ranged from 1.17 to 3.84. According to the industry distribution chart, Jinhai Medical Technology ranks #166 out of 550 companies in the Conglomerates industry, placing it in the top 30.2%.
Is Jinhai Medical Technology's Quick Ratio too high?
Jinhai Medical Technology's current Quick Ratio of 1.75 is 23% below median its 10-year median of 2.26. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 3.84. The Conglomerates industry median Quick Ratio is 1.16. Jinhai Medical Technology's value of 1.75 is 50.9% above this industry median. Based on the distribution chart, Jinhai Medical Technology ranks #166 out of 550 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Jinhai Medical Technology has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinhai Medical Technology's Quick Ratio compare to RHI and KFY?
According to the Conglomerates industry distribution chart, Jinhai Medical Technology ranks #166 out of 550 companies for Quick Ratio. This puts Jinhai Medical Technology in the upper half of its industry. The industry median Quick Ratio is 1.16. Jinhai Medical Technology's value of 1.75 is 50.9% above this benchmark. Historically, Jinhai Medical Technology's own Quick Ratio has ranged from 1.17 to 3.84 over the past decade. While the company's 10-year median is 2.26 vs. the industry median of 1.16, Jinhai Medical Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Conglomerates company?
The median Quick Ratio among Conglomerates companies is 1.16, based on 550 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinhai Medical Technology's current Quick Ratio of 1.75 is 50.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Jinhai Medical Technology and its competitors. For the Conglomerates industry, the median Quick Ratio is 1.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinhai Medical Technology's current Quick Ratio is 1.75, which is 23% below median its own 10-year median of 2.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinhai Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Jinhai Medical Technology (HKSE:02225) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$1.41, compared to a current price of HK$6.11 — trading 333% above its estimated fair value. The current Quick Ratio is 1.75, which is 23% below median its 10-year median of 2.26 and 50.9% above the Conglomerates industry median of 1.16. Jinhai Medical Technology's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Jinhai Medical Technology (HKSE:02225), the current Quick Ratio is 1.75 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinhai Medical Technology (HKSE:02225) Overvalued in 2026?
Based on GuruFocus' analysis, Jinhai Medical Technology stock appears to be overvalued.
The current stock price of HK$6.11 is trading 333% above its estimated GF Value™ of HK$1.41.
GuruFocus considers Jinhai Medical Technology to be Significantly Overvalued.
Key valuation signals for HKSE:02225:
Quick Ratio: 1.75 (23% below median its 10-year median of 2.26)
GF Value™: HK$1.41 vs. price of HK$6.11 (333% above fair value)
Industry Position: 50.9% above the Conglomerates median (#166 of 550)
No single metric tells the full story. See the HKSE:02225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinhai Medical Technology Ltd is an investment holding company. Along with its subsidiaries, it is principally engaged in providing medical equipment in China and manpower outsourcing and ancillary services to building and construction contractors in Singapore. The group also provides IT services, construction ancillary services (which comprise warehousing, cleaning, and building maintenance works), and dormitory services in Singapore. It generates maximum revenue from the sale of minimally invasive surgery solutions, medical products, and related services in the People's Republic of China.
61GF Score
Get the complete analysis for HKSE:02225
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02225 has been successfully added to your 
